News & Events

HTG Molecular Appoints Dr. Joseph Sparano as Lead of Its Clinical Scientific Advisory Board for Breast Cancer Program

TUCSON, Ariz. , Jan. 23, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has appointed Dr. Joseph Sparano as lead of its Breast Cancer Program Scientific Advisory Board (SAB).

full press release

Posted on:

Return To List

Page last updated